Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment

Kashi Raj Bhattarai(Pharmaceutical Biotechnology (Czechia)), Daniel Savic(St. Jude Children's Research Hospital), Mary V. Relling(St. Jude Children's Research Hospital), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Christopher S. Manring, Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Brennan P. Bergeron(St. Jude Children's Research Hospital), Daniel C. Ferguson(University at Buffalo, State University of New York), Robert J. Mobley(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), Wenjian Yang(St. Jude Children's Research Hospital), Sima Jeha(St. Jude Children's Research Hospital), Kelly R. Barnett(St. Jude Children's Research Hospital), Jonathan D. Diedrich(The Barbara Ann Karmanos Cancer Institute), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Satoshi Yoshimura(St. Jude Children's Research Hospital), Jun J. Yang(St. Jude Children's Research Hospital), Hiroto Inaba(St. Jude Children's Research Hospital), Elisabeth Paietta(Montefiore Medical Center), Mark R. Litzow(Mayo Clinic in Arizona), Kristine R. Crews(St. Jude Children's Research Hospital), Baranda S. Hansen(St. Jude Children's Research Hospital), Cheng Cheng(St. Jude Children's Research Hospital), Wendy Stock(University of Chicago)
Nature Communications
May 1, 2024
Cited by 8


Related Papers